Untoward drug reaction real-time monitor

Abstract

The invention discloses a real-time adverse drug reaction monitor, and relates to the technical field of medical equipment. The system comprises a physical sign monitor. One side of the physical sign monitor is provided with an electrode patch, a near-infrared vein detector and a body temperature detector. A detection assembly is arranged on the other side of the physical sign monitor, the detection assembly comprises a visual detection probe, the visual detection probe is arranged at the top of the physical sign monitor, a supporting shell is installed on one side of the physical sign monitor, and a storage frame is arranged in the supporting shell. Through the arrangement of the detection assembly, tablets taken at a time can be put into the supporting shell before a patient takes medicine, the visual detection probe is used for shooting the tablets, the shape, color, texture and other characteristics of the tablets are extracted, then the type and number of the tablets taken at a time are judged, and meanwhile the correction function is achieved; and the dosage meets the standard, so that the adverse reaction can be effectively reduced.

Description

Technical Field

[0001] The invention belongs to the technical field of medical equipment, and in particular relates to a real-time monitoring instrument for adverse drug reactions. Background Art

[0002] Adverse drug reaction monitoring is an important part of ensuring patient safety. It can promptly detect and deal with adverse reactions caused by drugs, reduce medical risks, and promptly detect adverse reactions, which helps prevent more serious consequences. Through monitoring, drug treatment plans can be adjusted to improve treatment effects. Collecting adverse reaction data is of great value to drug safety assessments and future research and development. Medical staff, patients and their families should participate together, establish a good communication and feedback mechanism, and promptly identify and deal with adverse drug reactions.

[0003] In the prior art, a Chinese patent with publication number "CN221654286U" discloses a data acquisition device for monitoring adverse drug reactions, which is provided with a processing module and an electromagnetic induction patch. The electromagnetic induction patch is attached to the surface of human skin to collect blood flow rate information, body surface temperature, body surface secretion fluid substances, etc., and the data is fed back to the processing module for comparison and analysis with normal data, so as to monitor whether the human body has adverse reactions, and display data and prompts on a display screen, which solves the problem that the battery of the current handheld adverse drug reaction monitor is usually integrated and has short battery life, and the monitoring method is indirect monitoring, the accuracy of data acquisition is not high, and the best treatment time is easily missed.

[0004] However, the above device still has the following problems in the implementation process: when the patient's physical signs are detected by the detection instrument, after the patient has an adverse reaction, only the patient's physical sign data can be recorded, but the patient's medication process is missing. The cause of the patient's adverse reaction is affected by the dosage and type of medication. When the doctor detects the cause of the disease, he can only ask questions, resulting in inaccurate recorded data, which affects the judgment result of the cause of the adverse reaction. To this end, we provide a real-time monitoring device for adverse drug reactions to solve the above problems. Summary of the invention

[0005] The purpose of the present invention is to provide a real-time monitoring instrument for adverse drug reactions. Through the cooperation of a detection component, a weighing component and a control component, the problem that the adverse drug reaction monitoring instrument in the prior art lacks the function of recording the medication process is solved. When doctors detect the cause of the disease, they can only inquire about the dosage and type of medication by asking questions, which leads to inaccurate recorded data.

[0006] In order to solve the above technical problems, the present invention is achieved through the following technical solutions:

[0007] The present invention is a real-time monitoring instrument for adverse drug reactions, comprising a physical sign monitor, one side of which is provided with an electrode patch, a near-infrared vein detector and a body temperature detector;

[0008] A detection component is provided on the other side of the vital sign monitor, and the detection component includes a visual detection probe, and the visual detection probe is provided on the top of the vital sign monitor. A support shell is installed on one side of the vital sign monitor, and a storage frame is provided inside the support shell. The type and quantity of the tablets are recorded by the detection component;

[0009] A weighing assembly is provided inside the storage frame, and the weighing assembly includes a storage slot, and the storage slot is opened inside the storage frame, and a weighing sensor is installed inside the storage slot, and the weight of the tablets is weighed by the weighing assembly;

[0010] A control component is provided on the top of the vital sign monitor, and the control component includes a controller. The controller is installed on the top of the vital sign monitor. The controller is bidirectionally electrically connected to a networking module, a data storage module, a data comparison module, a display module and an identity collection module. The output end of the controller is unidirectionally electrically connected to an alarm module, and the patient's medication information is fed back through the control component.

[0011] The present invention is further configured such that the controller is bidirectionally electrically connected to the vital sign monitor, a first connecting wire is installed on the rear side of the electrode patch and the temperature detector, and the other end of the first connecting wire is fixedly connected to the vital sign monitor.

[0012] The present invention is further configured such that a second connecting line is installed at the rear side of the near-infrared vein detector, and the other end of the second connecting line is fixedly connected to the vital sign monitor.

[0013] The present invention is further configured such that a weighing plate is installed on the top of the weighing sensor, and the diameter of the weighing plate is smaller than the inner diameter of the storage tank.

[0014] The present invention is further configured such that a driving motor is installed on one side of the supporting shell, a transmission shaft is fixedly connected to an output end of the driving motor, and the other end of the transmission shaft penetrates the supporting shell and is fixedly connected to the storage frame.

[0015] The present invention is further configured such that a discharge pipe is connected to the bottom of the support shell, a collection box is provided at the bottom of the discharge pipe, and a pull ring is fixedly connected to one side of the collection box.

[0016] The present invention is further configured such that the front and rear sides of the collection box are fixedly connected to guide rails, a support plate is slidably connected to the surface of the guide rails, and one side of the support plate is fixedly connected to the vital sign monitor.

[0017] The present invention is further configured such that the alarm module includes a speaker and an audible and visual alarm, the controller input end is unidirectionally electrically connected to a power supply module, and the power supply module uses a battery.

[0018] The present invention is further configured such that a handle is fixedly connected to the top of the vital sign monitor, the identity collection module uses an ID card reader, and a bracket is fixedly connected between the visual detection probe and the vital sign monitor.

[0019] The present invention is further configured such that a strap is fixedly connected to the top of the near-infrared vein detector, a fixing ring is sleeved on the surface of the strap, and the bottom of the fixing ring is fixedly connected to the near-infrared vein detector.

[0020] The present invention has the following beneficial effects:

[0021] 1. Through the setting of the detection component, the present invention can put the tablets for single use into the supporting shell before the patient takes the medicine, and use the visual detection probe to shoot the tablets, extract the shape, color, texture and other characteristics of the tablets, and then judge the type and quantity of the tablets for single use, and realize the correction function at the same time to prevent the patient from exceeding the dosage. The dosage of the medicine meets the standard and can effectively reduce adverse reactions.

[0022] 2. Through the arrangement of the weighing assembly, the present invention can use the driving motor to drive the storage frame to tilt left and right after the visual detection probe has completed the detection of the type and quantity of the tablets, so that the tablets fall evenly into the storage slot, and use the weighing sensor to weigh the dosage of multiple groups of tablets, record the dosage of a single dose, and provide data for subsequent investigation of the causes of adverse reactions.

[0023] 3. Through the setting of the control component, the present invention can record the patient's identity information through the identity collection module, and connect with the hospital database system through the networking module, retrieve the medication data and contraindications prescribed by the doctor for the patient, and match them with the patient's identity record, list whether the patient has a history of allergies or genetic diseases, and be able to record and upload data after the patient has adverse reactions.

[0024] Of course, any product implementing the present invention does not necessarily need to achieve all of the advantages described above at the same time. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for describing the embodiments are briefly introduced below.

[0026] Figure 1 This is a structural stereogram of a real-time monitoring device for adverse drug reactions;

[0027] Figure 2This is a schematic diagram of the explosion of the surface structure of the support shell in the real-time monitoring device for adverse drug reactions;

[0028] Figure 3 It is a side cross-sectional view of a support shell in a real-time monitoring device for adverse drug reactions;

[0029] Figure 4 It is a side cross-sectional view of a storage frame in a real-time monitoring device for adverse drug reactions;

[0030] Figure 5 It is a schematic diagram of the rotation of the storage frame in the real-time monitoring instrument for adverse drug reactions;

[0031] Figure 6 This is a structural side view of the real-time monitoring device for adverse drug reactions;

[0032] Figure 7 This is a schematic diagram of the system principle of the real-time monitoring instrument for adverse drug reactions.

[0033] In the attached drawings: 1. Vital sign monitor; 2. Electrode patch; 3. Near-infrared vein detector; 4. Temperature detector; 5. Visual detection probe; 6. Support shell; 7. Storage frame; 8. Storage tank; 9. Weighing sensor; 10. Controller; 11. Networking module; 12. Data storage module; 13. Data comparison module; 14. Display module; 15. Identity collection module; 16. Alarm module; 17. First connecting line; 18. Second connecting line; 19. Weighing plate; 20. Drive motor; 21. Drive shaft; 22. Discharge pipe; 23. Collection box; 24. Pull ring; 25. Guide rail; 26. Support plate; 27. Power supply module; 28. Handle; 29. ​​Bracket; 30. Strap. DETAILED DESCRIPTION

[0034] The technical solutions in the embodiments of the present invention will be described below in conjunction with the drawings in the embodiments of the present invention. The described embodiments are only part of the embodiments of the present invention, rather than all the embodiments. Specific embodiment 1

[0036] See also Figure 1-7The present invention is a real-time monitor for adverse drug reactions, comprising a physical sign monitor 1, wherein an electrode patch 2, a near-infrared vein detector 3 and a body temperature detector 4 are respectively arranged on one side of the physical sign monitor 1; a detection component is arranged on the other side of the physical sign monitor 1, and the detection component comprises a visual detection probe 5, and the visual detection probe 5 is arranged on the top of the physical sign monitor 1; a support shell 6 is installed on one side of the physical sign monitor 1, and a storage frame 7 is arranged inside the support shell 6, and the type and quantity of the tablets are recorded by the detection component; a weighing component is arranged inside the storage frame 7, and the weighing component comprises a storage tank 8 The storage slot 8 is opened inside the storage frame 7, and a weighing sensor 9 is installed inside the storage slot 8. The weight of the tablets is weighed by the weighing component; a control component is arranged on the top of the vital sign monitor 1, and the control component includes a controller 10. The controller 10 is installed on the top of the vital sign monitor 1. The controller 10 is bidirectionally electrically connected to a networking module 11, a data storage module 12, a data comparison module 13, a display module 14 and an identity collection module 15. The output end of the controller 10 is unidirectionally electrically connected to an alarm module 16, and the patient's medication information is fed back through the control component.

[0037] Specifically: the electrode patch 2 can collect the patient's physiological data (such as electrocardiogram signals, electromyography signals, etc.) in real time, and timely discover possible adverse reactions caused by drugs by monitoring changes in physiological parameters, such as heart rate changes, blood pressure fluctuations, skin reactions, etc., providing clinicians with real-time and accurate means of monitoring the patient's physiological state, which can effectively improve the early identification ability of adverse reactions, help optimize medication plans, and ensure patient safety. The near-infrared vein detector 3 can use near-infrared light to pass through the skin and tissues. Hemoglobin has different absorption characteristics for light of different wavelengths. By analyzing the intensity changes of the reflected light, the ratio of oxygenated and deoxygenated hemoglobin in the blood can be calculated. The monitor analyzes the reflected light signal in real time to generate parameters such as blood oxygen saturation and blood flow. The impact of drugs on blood circulation and oxygenation is judged by monitoring the results, and potential adverse reactions are identified. The body temperature detector 4 usually uses components such as thermocouples, infrared sensors or thermistors to sense body temperature and convert it into electrical signals, which are used to monitor adverse reactions such as fever or infection during drug treatment. Specific embodiment 2

[0039] See also Figure 1-7On the basis of the first specific embodiment, the controller 10 is bidirectionally electrically connected to the vital sign monitor 1, the electrode patch 2 and the body temperature detector 4 are both installed with a first connecting line 17 on the rear side, and the other end of the first connecting line 17 is fixedly connected to the vital sign monitor 1, a second connecting line 18 is installed on the rear side of the near-infrared vein detector 3, and the other end of the second connecting line 18 is fixedly connected to the vital sign monitor 1, a weighing plate 19 is installed on the top of the weighing sensor 9, and the diameter of the weighing plate 19 is smaller than the inner diameter of the storage tank 8, a driving motor 20 is installed on one side of the support shell 6, and a transmission shaft 21 is fixedly connected to the output end of the driving motor 20, and the other end of the transmission shaft 21 passes through the support shell 6 and is fixedly connected to the storage frame 7.

[0040] Specifically: Through the visual detection probe 5, the color, shape, size and logo of the tablets can be accurately identified to ensure that the medicine taken by the patient is the correct medicine prescribed by the doctor and to prevent medication errors. Each test result can be recorded to form an electronic file for easy traceability and supervision. There are nine storage slots 8, which can store multiple groups of tablets at the same time. The weighing sensor 9 can weigh the weight of the tablets, detect damaged tablets, and record the weight of the medicine. Specific embodiment three

[0042] See also Figure 1-7 On the basis of the specific embodiment 1, a discharge pipe 22 is connected to the bottom of the support shell 6, a collection box 23 is arranged at the bottom of the discharge pipe 22, a pull ring 24 is fixedly connected to one side of the collection box 23, a guide rail 25 is fixedly connected to the front and rear sides of the collection box 23, a support plate 26 is slidably connected to the surface of the guide rail 25, one side of the support plate 26 is fixedly connected to the vital sign monitor 1, the alarm module 16 includes a speaker and an audible and visual alarm, a power supply module 27 is unidirectionally electrically connected to the input end of the controller 10, the power supply module 27 adopts a battery, a handle 28 is fixedly connected to the top of the vital sign monitor 1, the identity collection module 15 adopts an ID card reader, a bracket 29 is fixedly connected between the visual detection probe 5 and the vital sign monitor 1, a strap 30 is fixedly connected to the top of the near-infrared vein detector 3, a fixing ring is sleeved on the surface of the strap 30, and the bottom of the fixing ring is fixedly connected to the near-infrared vein detector 3.

[0043] Specifically: the surface of the transmission shaft 21 is movably connected to the inner wall of the support shell 6 through a bearing, so as to transmit the power of the driving motor 20; the collection box 23 can store the tablets after the weighing test, so as to facilitate the patients to take medicine by themselves; the ID card reader can read the identity information, and the identity information can be matched before the patient uses the vital sign monitor 1; the surface of the strap 30 is fixed with Velcro, so as to fix the near-infrared vein detector 3 on the patient's wrist.

[0044] The working principle of the present invention is as follows: before the patient takes the medicine, the ID card is moved to the top of the controller 10, the ID card reader is used to collect the identity information, and the network module 11 is connected to the hospital database system to retrieve the medication data and contraindications prescribed by the doctor for the patient, and match them with the patient's identity record, and list whether the patient has a history of allergies and genetic diseases, and can record and upload data after the patient has adverse reactions;

[0045] After that, the patient puts all the tablets to be taken at a time into the storage frame 7, and then starts the driving motor 20 through the external controller 10. The driving motor 20 cooperates with the transmission shaft 21 to drive the storage frame 7 to tilt back and forth, so that the tablets in the storage frame 7 roll and fall into the multiple storage slots 8. Then, the visual detection probe 5 is started to take pictures and samples the tablets, extract the shape, color, texture and other characteristics of the tablets, and then determine the type and quantity of the tablets taken at a time. At the same time, the correction function is realized to prevent the patient from taking excessive dosage. The dosage of the medicine meets the standard, which can effectively reduce adverse reactions. At the same time, the dosage of the tablets is weighed by the weighing sensor 9;

[0046] Then, the data comparison module 13 is used to compare with the medication information prescribed by the doctor to prevent overdose, and the current medication information is recorded to facilitate tracing the cause of adverse reactions;

[0047] Then the drive motor 20 is started again, and the drive motor 20 drives the storage frame 7 to rotate downward, so that the tablets fall into the collection box 23, which is convenient for the patient to take out the medicine. After the patient takes the medicine, the electrode patch 2 can be attached to a suitable attachment part, such as the chest, arm or leg, and by monitoring the changes in physiological parameters, the adverse reactions that may be caused by the drug, such as heart rate changes, blood pressure fluctuations, skin reactions, etc., can be discovered in time;

[0048] At the same time, the near-infrared vein detector 3 is worn on the patient's wrist, and the effects of the drugs on blood circulation and oxygenation are judged through the monitoring results to identify potential adverse reactions. The temperature detector 4 usually uses components such as thermocouples, infrared sensors or thermistors to sense body temperature and convert it into electrical signals, which are used to monitor adverse reactions such as fever or infection during drug treatment. The patient can be comprehensively tested, and when the patient has discomfort symptoms, the information can be sent out immediately to alarm and provide first aid to the patient.

[0049] The standard parts used in the present invention can all be purchased from the market, and can be customized according to the description in the specification and drawings. The specific connection methods of each part adopt conventional means such as mature bolts, rivets, welding, etc. in the prior art. Machinery, parts and equipment all adopt conventional models in the prior art. The control method is automatically controlled by a control unit. The control circuit of the control unit can be realized by simple programming by technicians in this field, which is common knowledge in this field, so the control method and circuit connection are not explained in detail in the present invention.

[0050] The preferred embodiments of the present invention disclosed above are only used to help explain the present invention. The preferred embodiments do not describe all the details in detail, nor do they limit the invention to the specific implementation methods described. This specification selects and specifically describes these embodiments in order to better explain the principles and practical applications of the present invention, so that technicians in the relevant technical field can better understand and utilize the present invention.

Claims

1. A real-time monitoring device for adverse drug reactions, comprising a physical sign monitor (1), characterized in that: An electrode patch (2), a near-infrared vein detector (3) and a body temperature detector (4) are respectively arranged on one side of the vital sign monitor (1); A detection component is arranged on the other side of the vital sign monitor (1), and the detection component comprises a visual detection probe (5), and the visual detection probe (5) is arranged on the top of the vital sign monitor (1). A support shell (6) is installed on one side of the vital sign monitor (1), and a storage frame (7) is arranged inside the support shell (6). The detection component is used to record the type and quantity of the tablets. A weighing assembly is arranged inside the storage frame (7), and the weighing assembly comprises a storage slot (8). The storage slot (8) is opened inside the storage frame (7), and a weighing sensor (9) is installed inside the storage slot (8). The weight of the tablets is weighed by the weighing assembly; A control component is arranged on the top of the vital sign monitor (1), and the control component comprises a controller (10). The controller (10) is installed on the top of the vital sign monitor (1), and the controller (10) is bidirectionally electrically connected to a networking module (11), a data storage module (12), a data comparison module (13), a display module (14) and an identity collection module (15). The output end of the controller (10) is unidirectionally electrically connected to an alarm module (16), and the patient's medication information is fed back through the control component.

2. The real-time monitoring device for adverse drug reactions according to claim 1, characterized in that: The controller (10) is bidirectionally electrically connected to the vital sign monitor (1); a first connecting line (17) is installed on the rear side of the electrode patch (2) and the body temperature detector (4); and the other end of the first connecting line (17) is fixedly connected to the vital sign monitor (1).

3. The real-time monitoring device for adverse drug reactions according to claim 1, characterized in that: A second connecting line (18) is installed on the rear side of the near-infrared vein detector (3), and the other end of the second connecting line (18) is fixedly connected to the vital sign monitor (1).

4. The real-time monitoring device for adverse drug reactions according to claim 1, characterized in that: A weighing plate (19) is installed on the top of the weighing sensor (9), and the diameter of the weighing plate (19) is smaller than the inner diameter of the storage tank (8).

5. The real-time monitoring device for adverse drug reactions according to claim 1, characterized in that: A driving motor (20) is installed on one side of the supporting shell (6); an output end of the driving motor (20) is fixedly connected to a transmission shaft (21); the other end of the transmission shaft (21) passes through the supporting shell (6) and is fixedly connected to the storage frame (7).

6. The real-time monitoring device for adverse drug reactions according to claim 1, characterized in that: The bottom of the support shell (6) is connected to a discharge pipe (22), a collection box (23) is provided at the bottom of the discharge pipe (22), and a pull ring (24) is fixedly connected to one side of the collection box (23).

7. The real-time monitoring device for adverse drug reactions according to claim 6, characterized in that: The front and rear sides of the collection box (23) are both fixedly connected to guide rails (25), the surface of the guide rails (25) is slidably connected to a support plate (26), and one side of the support plate (26) is fixedly connected to the vital sign monitor (1).

8. The real-time monitoring device for adverse drug reactions according to claim 1, characterized in that: The alarm module (16) comprises a speaker and an audible and visual alarm, and the input end of the controller (10) is unidirectionally electrically connected to a power supply module (27), wherein the power supply module (27) uses a storage battery.

9. The real-time monitoring device for adverse drug reactions according to claim 1, characterized in that: A handle (28) is fixedly connected to the top of the vital sign monitor (1), the identity acquisition module (15) adopts an identity card reader, and a bracket (29) is fixedly connected between the visual detection probe (5) and the vital sign monitor (1).

10. The real-time monitoring device for adverse drug reactions according to claim 1, characterized in that: A binding strap (30) is fixedly connected to the top of the near-infrared vein detector (3), a fixing ring is sleeved on the surface of the binding strap (30), and the bottom of the fixing ring is fixedly connected to the near-infrared vein detector (3).

Images